| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.19 | 0.0003 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0004 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0006 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0008 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0009 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |